BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35955438)

  • 1. FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition.
    Li R; Okada H; Yamashita T; Nio K; Chen H; Li Y; Shimakami T; Takatori H; Arai K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma.
    Zhang B; Zhang Y; Zou X; Chan AW; Zhang R; Lee TK; Liu H; Lau EY; Ho NP; Lai PB; Cheung YS; To KF; Wong HK; Choy KW; Keng VW; Chow LM; Chan KK; Cheng AS; Ko BC
    J Pathol; 2017 Dec; 243(4):418-430. PubMed ID: 28862757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma.
    Yu M; Tang Z; Meng F; Tai M; Zhang J; Wang R; Liu C; Wu Q
    Tumour Biol; 2016 Jan; 37(1):1289-97. PubMed ID: 26289845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1.
    Chai N; Xie HH; Yin JP; Sa KD; Guo Y; Wang M; Liu J; Zhang XF; Zhang X; Yin H; Nie YZ; Wu KC; Yang AG; Zhang R
    Biochem Biophys Res Commun; 2018 Jun; 500(4):924-929. PubMed ID: 29705704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinoma.
    Tian C; Wu H; Li C; Tian X; Sun Y; Liu E; Liao X; Song W
    Gene Ther; 2018 Jul; 25(4):312-319. PubMed ID: 29973656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
    Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
    J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
    Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY
    Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
    Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
    Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
    Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
    BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
    Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
    Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.
    Shang R; Pu M; Li Y; Wang D
    Oncol Rep; 2017 Apr; 37(4):2261-2269. PubMed ID: 28260073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormones suppress FOXM1 expression to reduce liver cancer progression.
    Wu CH; Yeh CT; Lin KH
    Oncol Rep; 2020 Oct; 44(4):1686-1698. PubMed ID: 32945493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XTP8 promotes hepatocellular carcinoma growth by forming a positive feedback loop with FOXM1 oncogene.
    Han M; Lu H; Han K; Yuan X; Liu S; Wang Y; Zhao J; Liang P; Cheng J
    Biochem Biophys Res Commun; 2019 Jul; 515(3):455-461. PubMed ID: 31164201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-216b is downregulated in hepatocellular carcinoma and inhibits HepG2 cell growth by targeting Forkhead box protein M1.
    Zheng WW; Zhou J; Zhang CH; Liu XS
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2541-50. PubMed ID: 27383303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isovitexin reduces carcinogenicity and stemness in hepatic carcinoma stem-like cells by modulating MnSOD and FoxM1.
    Cao X; Liu L; Yuan Q; Li X; Cui Y; Ren K; Zou C; Chen A; Xu C; Qiu Y; Quan M; Zhang J; Cao J; Chen X
    J Exp Clin Cancer Res; 2019 Jun; 38(1):264. PubMed ID: 31208440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXM1 augments sorafenib resistance and promotes progression of hepatocellular carcinoma by epigenetically activating KIF23 expression.
    Zhu C; Guo H; Ma Z; Shi S; Zhao X; Zhai D; Zhou X; Jiang P; Xu Q; Cai J
    Biochem Biophys Res Commun; 2023 May; 656():1-9. PubMed ID: 36940637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing Roles of the Forkhead Box Factors FoxM1 and FoxA2 in Liver Cancer.
    Chand V; Pandey A; Kopanja D; Guzman G; Raychaudhuri P
    Mol Cancer Res; 2019 May; 17(5):1063-1074. PubMed ID: 30814128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
    Wei JC; Meng FD; Qu K; Wang ZX; Wu QF; Zhang LQ; Pang Q; Liu C
    Acta Pharmacol Sin; 2015 Feb; 36(2):241-51. PubMed ID: 25557114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.